📖 Approx. 8 min
In M&A of medical corporations (medical practice succession), contract signing and closing are not the final goals but merely the starting line for new management. The success of medical M&A hinges on the post-deal integration process, known as “PMI (Post-Merger Integration),” and particularly on the execution of the initial “100-Day Plan.” This article provides a detailed, expert perspective on the specific practicalities and success points of the 100-day plan following medical M&A, considering the unique systems, medical fee structures, licenses, and human resource management specific to medical corporations.
The Importance of PMI in Medical M&A and Differences from General Corporations
Unlike M&A in general corporations, PMI for medical institutions involves unique issues such as strict regulations under the Medical Care Act, the specific role in regional healthcare, and adaptation to the medical fee reimbursement system. For instance, procedural differences based on the presence or absence of equity shares, notification of director changes to prefectural governments, applications/notifications for operating licenses to public health centers, and applications for designation as an insurance medical institution to regional bureaus of health and welfare. Delays in administrative procedures can lead to the critical risk of a “period without medical fee claims (uninsured medical treatment period).”
Furthermore, reconfirming the institution’s position within the regional healthcare plan (bed functions and regional roles), and preventing the departure of highly specialized professionals such as doctors, nurses, and paramedical staff, require extremely delicate management. Delays in PMI can lead to a decline in the quality of medical services and staff distrust, ultimately resulting in patient attrition and business decline. Therefore, planning for PMI must begin during the due diligence (DD) phase before the deal is finalized.
Three Major Areas of Consideration in Medical Institution PMI
PMI for medical institutions can be broadly categorized into three areas: “Integration of Governance,” “Integration of Operations and Systems,” and “Integration of Organization and Culture.” Harmonizing these elements is key to success.
100-Day Plan Timeline and Step Flow
The 100-Day Plan is a roadmap outlining critical measures to be implemented within approximately three months from closing (Day 1). It is generally said that the actions taken during the first 100 days determine the stability of the new system thereafter.
- 【Day 1 ~ Day 14】Building Initial Trust and Understanding the Current Situation: Hold explanatory meetings (town hall meetings) for all staff, conduct individual meetings with key personnel, and confirm urgent cash flow and contractual matters.
- 【Day 15 ~ Day 45】Establishing Governance Structure and Administrative Procedures: Hold board of directors’ meetings with new officers, complete various notifications and applications to public health centers and regional bureaus of health and welfare, and transition financial and accounting management processes.
- 【Day 46 ~ Day 75】Visualizing and Improving Operations/Clinical Processes: Identify bottlenecks in clinical workflows, verify the operation of electronic health records and medical accounting systems, and review purchasing and outsourcing (e.g., laboratory testing, medical waste disposal).
- 【Day 76 ~ Day 100】Formulating Mid-Term Management Plan and Preparing New Evaluation System: Develop a new budget reflecting synergy effects, initiate review of personnel evaluation and wage systems, and establish internal communication.
On Day 1 (closing day), it is essential for the new chairman and director to clearly communicate to all staff the background of the succession, express respect for the previous management, and state their commitment to “maintaining employment” and “respecting the previous medical policies.” Addressing staff’s psychological anxieties early on forms the foundation for a smooth process going forward.
Governance Transition and Practicalities of Shareholder/Member and Director Changes in Medical Corporations
In M&A of medical corporations, the transition of governance involves the presence or absence of “equity shares” and securing control over the “members’ assembly” and “board of directors,” which are the decision-making bodies of the corporation. The practical considerations vary significantly depending on the type of medical corporation.
| Item | Medical Corporation with Equity Shares (Transitional Measure Medical Corporation) | Medical Corporation without Equity Shares (Funded Type, etc.) |
|---|---|---|
| Subject of Succession/Transfer | Transfer of equity shares (transfer of property rights) | Change of members/directors (transfer of decision-making authority) and refund/contribution of funds |
| Members’ Assembly Measures | Since it is “one vote per person” regardless of equity ratio, the buyer must secure a majority of members (two-thirds or more for special resolutions). | As there are no equity shares, ensure that members designated by the buyer are appointed through the procedures for joining and leaving. |
| Tax Implications | “Capital gains tax” upon transfer of equity shares (20.315% in principle). The appropriateness of fair market value assessment is questioned. | Tax treatment upon refund of funds. Be aware of risks such as deemed dividend taxation. |
Particularly in “medical corporations without equity shares,” improper procedures for changing members carry the risk of serious governance disputes, such as former management-related parties claiming voting rights later. Meticulous practical scheduling is required, such as receiving resignation letters simultaneously with closing and carrying out the procedures for appointing new members on the same day. Furthermore, since registration applications for changes in the board chairman must be filed within two weeks of the change, application documents for the Legal Affairs Bureau must be prepared in advance.
Ensuring Succession of Medical Fees, Facility Standards, and Licenses
The management foundation of a medical institution depends on maintaining medical fee reimbursements and facility standards. The administrative procedures vary greatly depending on the M&A scheme (change of corporate members/directors or business transfer).
In the case of succession through “member and director changes” in a medical corporation, the legal identity of the corporation is maintained, so it generally does not constitute a “change of operator.” In this case, notifications such as “Partial Change Notification of Operator’s Details” to the public health center and “Notification of Changes in Insurance Medical Institution Details” to the regional bureau of health and welfare will be submitted promptly afterward. This ensures that the right to claim medical fees is maintained without interruption.
On the other hand, if the scheme involves the incorporation of a private clinic or a “business transfer” to a separate corporation, the procedures become extremely complex. It is necessary to simultaneously proceed with the “Notification of Cessation” by the former operator and the “Application for Operating License/Notification of Operation” by the new operator, as well as apply for “New Designation Application for Insurance Medical Institution” to the regional bureau of health and welfare. Designation as an insurance medical institution is generally effective from the first day of each month, so all requirements must be met with application documents submitted by the designation deadline of the previous month (typically around the 10th of each month, varying by region). Even a one-day delay in procedures can lead to a “period without insurance” where medical services cannot be billed under insurance for a month, making prior consultation and coordination with administrative contact points an essential practical step.
Furthermore, regarding facility standards (such as nursing staff allocation standards and facility/equipment standards), it is necessary to reconfirm compliance with the requirements after succession and submit notifications under the new system. In particular, if requirements such as specialist qualifications are no longer met due to a change in doctors, the medical fee calculation rank may decrease (be reduced), making post-succession simulations indispensable.
Retention of Medical Professionals and Change Management (Preventing Turnover)
One of the biggest failure factors in medical M&A is the departure of key personnel such as doctors, nurses, and medical technicians (paramedicals). Medical professionals have high mobility in the labor market, and there is a risk of mass resignations (organizational collapse) due to anxiety about management changes or resistance to new medical policies and operational rules.
- Start with “Maintaining the Status Quo”: For the first 30-60 days, avoid drastic changes to operational workflows, electronic health records, or clinical systems. First, respect the現場’s (on-site) “way of doing things” and focus on observation.
- Conduct One-on-One Meetings: Hold individual meetings with all staff by Day 30 to carefully listen to their concerns about compensation, current operational challenges, and requests for the new system.
- Early Engagement of Key Personnel: Communicate to key individuals with strong influence on-site, such as the head nurse, supervisors, and administrative director, that they are expected to be right-hand persons to the new management, and build a special relationship of trust.
- Gradual Infusion of Philosophy: Instead of unilaterally imposing new management philosophies or visions, demonstrate a “co-creative” approach that leverages the existing strengths of the site.
To alleviate staff’s psychological resistance (reactance), it is crucial to demonstrate through actions that “management is on the side of the staff and has come to create a better working environment.” For example, providing visible benefits to staff early on, such as updating aging medical equipment or improving the break room environment, is highly effective in gaining trust.
Integration of Tax and Finance, and Handling of Special Measures for Business Tax
In the process of integrating financial and accounting functions during PMI, it is important to be aware of tax issues unique to medical corporations. Particularly important is the treatment of the “exemption measure for business tax on social insurance medical fees (Article 72-23 of the Local Tax Act).” For medical corporations, income from social insurance medical fees is exempt from business tax. However, if the proportion of private practice (out-of-pocket services) or long-term care insurance business increases, it is necessary to accurately calculate the portion of income subject to taxation. If changes in medical specialties or expansion of private practice are planned after succession, it is required to simulate in advance how the business tax burden will change.
Additionally, if a business transfer scheme is adopted, it is necessary to appropriately determine the tax treatment for consumption tax on transferred assets (exempt for land and medical equipment related to social insurance medical fees; taxable for buildings, goodwill, etc.). In particular, the consumption tax burden on the valuation of “goodwill (norei)” and its subsequent tax depreciation treatment (e.g., straight-line depreciation over 5 years) significantly impacts cash flow. Furthermore, if the payment of retirement allowances to the former chairman is involved, it is necessary to properly record and preserve the decision-making process of the members’ assembly, etc., to meet the deductibility requirements for corporate tax purposes (fact of retirement, appropriate amount based on retirement allowance regulations, etc.).
For Consultations on Medical Practice Succession and Post-Medical M&A PMI, Contact M&A Medical
PMI in medical M&A requires meticulousness and a deep understanding of the healthcare industry, going beyond general corporate M&A, due to the complexity of legal procedures, the mental care of medical professionals, and the maintenance of medical systems. M&A Medical (operated by CentralMedience Inc.) is an M&A support institution certified by the Small and Medium Enterprise Agency. Our specialized consultants, who are well-versed in the unique issues of the healthcare industry, will provide consistent support from before the deal closes through the planning and execution of the “100-Day Plan” after closing. Directors and presidents concerned about a smooth post-succession launch or governance and operational integration are encouraged to contact our free consultation service.
Consultations on Medical Succession with M&A Medical
M&A Medical is a specialized M&A and business succession support service for medical institutions. As an M&A support institution certified by the Small and Medium Enterprise Agency, we support everything from the transfer of clinics and medical corporations struggling with a lack of successors to strategic acquisitions on a success-fee basis.
- Initial consultation and preliminary assessment are free
- No upfront fees or monthly charges (success fee only)
- Strict confidentiality (proceeding under NDA)
- Services available nationwide for all medical specialties
Please consult with us early in your consideration phase, whether you “just want to know the market price,” “have no successor,” or are “considering joining a group.”